Mary Frances Wedekind, Srivandana Akshintala, Brigitte C. Widemann, Charles Minard, Olga Militano, David Hall, Zanette Bradley, Joel M. Reid, Joseph Gerald Pressey, Elad Sharon, Jennie Haunani Foster, Elizabeth Fox, Brenda Weigel. "Phase 1/2 study of tiragolumab and atezolizumab in patients with relapsed or refractory SMARCB1- or SMARCA4-deficient tumors: PEPN2121.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps2695